The Heart and Cardiac Pacing in Steinert Disease

Overview

Journal Acta Myol

Date 2012 Oct 26

PMID 23097601

Citations 17

Authors

Gerardo Nigro

Andrea Antonio Papa

Luisa Politano

Affiliations

Soon will be listed here.

Abstract

Myotonic dystrophy (Dystrophia Myotonica, DM) is the most frequently inherited neuromuscular disease of adult life. It is a multisystemic disease with major cardiac involvement. Core features of myotonic dystrophy are myotonia, muscle weakness, cataract, respiratory failure and cardiac conduction abnormalities. Classical DM, first described by Steinert and called Steinert's disease or DM1 (Dystrophia Myotonica type 1) has been identified as an autosomal dominant disorder associated with the presence of an abnormal expansion of a CTG trinucleotide repeat in the 3' untranslated region of DMPK gene on chromosome 19. This review will mainly focus on the various aspects of cardiac involvement in DM1 patients and the current role of cardiac pacing in their treatment.

Citing Articles

Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review.

Politano L Int J Mol Sci. 2024; 25(10.

PMID: 38791328 PMC: 11121328. DOI: 10.3390/ijms25105289.

Emergencies cards for neuromuscular disorders 1 Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report.

Racca F, Sansone V, Ricci F, Filosto M, Pedroni S, Mazzone E Acta Myol. 2023; 41(4):135-177.

PMID: 36793651 PMC: 9896597. DOI: 10.36185/2532-1900-081.

Gender effect on onset, prevalence and surgical treatment of cataract in patients with Myotonic Dystrophy type 1.

Scutifero M, Lanza M, Petillo R, De Bernardo M, Passamano L, Rosa N Acta Myol. 2022; 41(3):105-110.

PMID: 36349183 PMC: 9628803. DOI: 10.36185/2532-1900-N75.

Silent dysphagia in two patients with Steinert disease and recurrent respiratory exacerbations.

Annunziata A, Valente T, Cauteruccio R, Fiorentino G Acta Myol. 2020; 39(3):141-143.

PMID: 33305171 PMC: 7711324. DOI: 10.36185/2532-1900-019.

Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1.

Palladino A, De Bernardo M, Scutifero M, Lanza M, De Querquis S, Rosa N Acta Myol. 2020; 39(2):90-93.

PMID: 32904905 PMC: 7460729. DOI: 10.36185/2532-1900-011.

References

Politano L, Palladino A, Nigro G, Scutifero M, Cozza V . Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol. 2009; 27:114-22. PMC: 2858940. View

Phillips M, Harper P . Cardiac disease in myotonic dystrophy. Cardiovasc Res. 1997; 33(1):13-22. DOI: 10.1016/s0008-6363(96)00163-0. View

Harley H, Brook J, Rundle S, Crow S, Reardon W, Buckler A . Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992; 355(6360):545-6. DOI: 10.1038/355545a0. View

Morner S, Lindqvist P, Mellberg C, Olofsson B, Backman C, Henein M . Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1. J Intern Med. 2010; 268(1):59-65. DOI: 10.1111/j.1365-2796.2010.02213.x. View

Nigro G, Russo V, Politano L, Della Cioppa N, Rago A, Arena G . Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study. Europace. 2010; 12(9):1219-23. DOI: 10.1093/europace/euq170. View

Nigro G, Russo V, Ventriglia V, Della Cioppa N, Palladino A, Nigro V . Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2010; 20(3):174-7. DOI: 10.1016/j.nmd.2009.12.004. View

Ammendola E, Russo V, Politano L, Santangelo L, Calabro R . Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy?. Heart. 2006; 92(11):1686-7. PMC: 1861247. DOI: 10.1136/hrt.2005.082909. View

Grigg L, Chan W, Mond H, Vohra J, Downey W . Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features. J Am Coll Cardiol. 1985; 6(1):254-6. DOI: 10.1016/s0735-1097(85)80286-2. View

DAndrea A, Salerno G, Scarafile R, Riegler L, Gravino R, Castaldo F . Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2009; 32(8):1017-29. DOI: 10.1111/j.1540-8159.2009.02434.x. View

10.

Paventi S, Bevilacqua U, Parafati M, Di Luzio E, Rossi F, Pelliccioni P . QT dispersion and early arrhythmic risk during acute myocardial infarction. Angiology. 1999; 50(3):209-15. DOI: 10.1177/000331979905000305. View

11.

Ogawa H, Ishikawa T, Matsushita K, Matsumoto K, Ishigami T, Sugano T . Effects of right atrial pacing preference in prevention of paroxysmal atrial fibrillation: Atrial Pacing Preference study (APP study). Circ J. 2008; 72(5):700-4. DOI: 10.1253/circj.72.700. View

12.

Olofsson B, Forsberg H, Andersson S, Bjerle P, Henriksson A, WEDIN I . Electrocardiographic findings in myotonic dystrophy. Br Heart J. 1988; 59(1):47-52. PMC: 1277071. DOI: 10.1136/hrt.59.1.47. View

13.

Mankodi A, Thornton C . Myotonic syndromes. Curr Opin Neurol. 2002; 15(5):545-52. DOI: 10.1097/00019052-200210000-00005. View

14.

Babuty D, Fauchier L, Poret P, Leche J, Raynaud M, Fauchier J . Significance of late ventricular potentials in myotonic dystrophy. Am J Cardiol. 1999; 84(9):1099-101, A10. DOI: 10.1016/s0002-9149(99)00510-x. View

15.

Barr C, Naas A, Freeman M, Lang C, Struthers A . QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994; 343(8893):327-9. DOI: 10.1016/s0140-6736(94)91164-9. View

16.

Nigro G, Russo V, Vergara P, DAndrea A, Di Gregorio G, Politano L . Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation. Pacing Clin Electrophysiol. 2008; 31(11):1463-6. DOI: 10.1111/j.1540-8159.2008.01210.x. View

17.

Clarke N, Kelion A, Nixon J, Hilton-Jones D, Forfar J . Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?. Heart. 2001; 86(4):411-6. PMC: 1729946. DOI: 10.1136/heart.86.4.411. View

18.

Rotundo I, Faraso S, De Leonibus E, Nigro G, Vitiello C, Lancioni A . Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy. PLoS One. 2011; 6(9):e24729. PMC: 3170375. DOI: 10.1371/journal.pone.0024729. View

19.

Emery A . The muscular dystrophies. Lancet. 2002; 359(9307):687-95. DOI: 10.1016/S0140-6736(02)07815-7. View

20.

Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J . Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation. 1999; 99(8):1041-6. DOI: 10.1161/01.cir.99.8.1041. View